Edesa Biotech (EDSA) Construction in Progress (2016 - 2019)
Edesa Biotech's Construction in Progress history spans 5 years, with the latest figure at $475373.0 for Q1 2019.
- For Q1 2019, Construction in Progress rose 80.21% year-over-year to $475373.0; the TTM value through Mar 2019 reached $475373.0, up 80.21%, while the annual FY2018 figure was $426265.0, 193.33% up from the prior year.
- Construction in Progress for Q1 2019 was $475373.0 at Edesa Biotech, up from $414004.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $475373.0 in Q1 2019 and bottomed at $32079.0 in Q3 2015.
- The 5-year median for Construction in Progress is $144232.5 (2016), against an average of $196152.4.
- The largest annual shift saw Construction in Progress crashed 54.54% in 2016 before it skyrocketed 341.96% in 2017.
- A 5-year view of Construction in Progress shows it stood at $165913.0 in 2015, then plummeted by 54.54% to $75426.0 in 2016, then soared by 32.8% to $100167.0 in 2017, then soared by 313.31% to $414004.0 in 2018, then grew by 14.82% to $475373.0 in 2019.
- Per Business Quant, the three most recent readings for EDSA's Construction in Progress are $475373.0 (Q1 2019), $414004.0 (Q4 2018), and $426265.0 (Q3 2018).